Global top pharmaceutical companies based on R&D spending 2024

Top 50 global pharmaceutical and biotech companies by R&D intensity in 2017/2018

Top pharmaceutical companies in R&D spending growth 2017-2018

Roche: participation of patients in clinical trials 2009-2017

Leading global contract research organizations based on revenue 2017

Comparison between the complexity of clinical trials 2001-2015

Increase in clinical trials' complexity 2001-2015

Number of registered clinical studies by location worldwide 2019

Percent of registered clinical studies worldwide by location 2019

Share of recruiting clinical studies worldwide by location 2019

Total number of registered clinical studies worldwide since 2000

Total number of registered clinical studies with posted results worldwide 2009-2019

Clinical trial enrollment by select country and region 2016

Top clinical trial participant countries 2015-2016, by number

Top clinical trial participant countries worldwide 2015-16, by share

Clinical trial participants U.S. vs. rest of world by therapy area 2016

Clinical trial participants gender share worldwide 2015-16, by geographic location

Clinical trial participants ethnicity share worldwide 2015-16, by geographic location

Pharmaceuticals: cost of drug development in the U.S. since 1975

Total R&D costs of select cancer drugs 2017

Market share of clinical trials worldwide by segment

Clinical CRO market size worldwide 2011-2020

Size of U.S. healthcare CRO market 2016-2022 by type

Size of total U.S. clinical trial supplies market 2016-2025

U.S. drug development phase success rates 2006-2015

U.S. drug development Phase II success rates 2006-2015, by disease area

U.S. drug development Phase III success rates from 2006 to 2015, by disease area

U.S. development Phase success rates for oncology and non oncology drugs 2006-2015

U.S. drug development Phase success rates, by drug classification 2006-2015

U.S. development phase success rates for drugs with and without biomarkers 2006-2015

Pharmaceutical industry - number of new substances 1992-2018

Number of novel drugs approved annually by CDER 2008-2018

Key measurements of U.S. CDER drug approvals in 2018

FDA first premarket approvals for medtech products granted 2005-2018

Projection of top 2018 pharma and biotech launches by revenue 2022

Number of unsuccessful Alzheimer’s drugs in development in the U.S. 1998-2017

Unsuccessful attempts and new drugs for cancer types 1998-2014